Enhanced Antitumor Activity of 3-Bromopyruvate in Combination with Rapamycin <i>In Vivo</i> and <i>In Vitro</i>
Qi Zhang(Shanghai Medical College of Fudan University), Ming You(Houston Methodist), Steven M. Komas(Medical College of Wisconsin), Balaraman Kalyanaraman(Medical College of Wisconsin), Ronald A. Lubet(National Cancer Institute), Jing Pan(Houston Methodist), Yian Wang(Hunan Normal University)
Cited by 23
Related Papers
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
|Nature Communications|2020|246
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
|Nature Communications|2019|242